New therapeutic options for persistent low-level viremia in patients with chronic hepatitis B virus infection: Increase of entecavir dosage

Chronic hepatitis B virus (HBV) infection (CHB) is a public health concern worldwide. Current therapies utilizing nucleos(t)ide analogs (NA) have not resulted in a complete cure for CHB. Furthermore, patients on long-term NA treatment often develop low-level viremia (LLV). Persistent LLV, in additio...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Guo-Qing, Li, Jun, Zhong, Bei, Yang, Yong-Fong, Wang, Mao-Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Opinion Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934007/
https://www.ncbi.nlm.nih.gov/pubmed/33716446
http://dx.doi.org/10.3748/wjg.v27.i8.666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934007/
https://www.ncbi.nlm.nih.gov/pubmed/33716446
http://dx.doi.org/10.3748/wjg.v27.i8.666

Ejemplares similares